Patent Application
Provisional
App. No. 62/985,802
· Confirmation No. 4356
METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH MYELOPEROXIDASE INHIBITOR
Applicant:
Biohaven Therapeutics Ltd.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-04-27 | OATH |
Oath or Declaration filed | 21 | View | |
| 2020-03-12 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2020-03-05 | ADS |
Application Data Sheet | 8 | View | |
| 2020-03-05 | SPEC |
Specification | 74 | View | |
| 2020-03-05 | CLM |
Claims | 7 | View | |
| 2020-03-05 | ABST |
Abstract | 1 | View | |
| 2020-03-05 | DRW.NONBW |
Drawings-other than black and white line drawings | 1 | View | |
| 2020-03-05 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-03-05 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2020-03-05 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2020-03-05 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Attorneys & Agents of Record
Prosecution
- Customer No.
- 164621
- Docket No.
- 20111-PROV
- Confirmation No.
- 4356
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.,
BIOHAVEN THERAPEUTICS LTD.,
BIOHAVEN PHARMACEUTICAL IRELAND DESIGNATED ACTIVITY COMPANY
RELEASE OF SECURITY INTEREST
Recorded 2025-04-27
from
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.,
BIOHAVEN PHARMACEUTICAL IRELAND DESIGNATED ACTIVITY COMPANY,
BIOHAVEN THERAPEUTICS LTD
PATENT SECURITY AGREEMENT
Recorded 2020-08-07
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2020-08-06
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 62/985,802
- Filed
- 2020-03-05
External Links